Enteric Disease Testing Market Worth USD 5.86 Billion by 2035 | SNS Insider

The global Enteric Disease Testing Market is valued at USD 4.08 billion in 2025 and is projected to reach USD 5.86 billion by 2035, growing at a CAGR of 3.70%. Growth is driven by increasing foodborne and waterborne disease prevalence, rising demand for rapid pathogen detection, and expanding adoption of multiplex molecular diagnostics. North America and Europe are leading markets, with Asia-Pacific emerging as the fastest-growing region.

06/23/2026, 4:35 AM • GlobeNewswire

[Latest] Healthcare Command Centers Market Size Will Attain USD 5.0 Billion by 2034 Registering a Promising CAGR of 10.8% - Exclusive Report by ZMR | Global Healthcare Command Centers Market Size, Share, Trends Analysis Report

The global healthcare command centers market is projected to grow from USD 1.8 billion in 2024 to USD 5.0 billion by 2034, with a CAGR of 10.8%. Growth is driven by rising demand for efficient patient flow management, digital transformation in hospitals, and operational optimization. Cloud-based deployment dominates with 49% market share, while software components lead with 48% share. North America holds 41% of the global market. However, high implementation costs and limited adoption in developing regions pose challenges.

06/18/2026, 12:50 PM • GlobeNewswire

Chemiluminescence Immunoassay Market Expected to Reach USD 16.39 Billion by 2031 | MarketsandMarkets™

The global chemiluminescence immunoassay (CLIA) market is projected to grow from USD 11.58 billion in 2026 to USD 16.39 billion by 2031, with a CAGR of 7.2%. Growth is driven by rising demand for high-sensitivity diagnostic testing, automated laboratory systems, increasing prevalence of chronic and infectious diseases, and technological advancements including AI-enabled automation. Asia Pacific is emerging as a high-growth region, while hospitals lead market adoption.

06/05/2026, 10:30 AM • GlobeNewswire

Global Cervical Cancer Diagnostics Market to Exhibit Growth at a CAGR of ~5% by 2034 | DelveInsight

The cervical cancer diagnostics market is projected to grow from USD 4.4 billion in 2025 to USD 7.1 billion by 2034 at a CAGR of ~5%. Growth is driven by rising cervical cancer prevalence, increasing adoption of advanced diagnostic technologies like HPV testing and AI-powered screening tools, government screening initiatives, and expanding healthcare infrastructure particularly in emerging economies. North America leads the market with 44% share in 2025.

05/14/2026, 1:00 PM • GlobeNewswire

Global Colorectal Cancer Diagnostics and Therapeutics Market Anticipates Impressive Growth Trajectory at a CAGR of ~9% by 2034 | DelveInsight

The global colorectal cancer diagnostics and therapeutics market is projected to grow from USD 35 billion in 2025 to USD 73 billion by 2034 at a CAGR of ~9%. Growth is driven by rising colorectal cancer prevalence, increased screening awareness, advancements in non-invasive diagnostics (liquid biopsy, stool-based DNA tests), and emerging targeted therapies and immunotherapies. North America leads with 41% market share, while Asia-Pacific is the fastest-growing region.

05/13/2026, 1:00 PM • GlobeNewswire

Computer Vision in Healthcare Market Report 2026: Revenue Expected to Surpass $33.4 Billion by 2036

The global computer vision in healthcare market is projected to grow from $4.37 billion in 2026 to $33.4 billion by 2036, at a CAGR of 22.6%. Growth is driven by AI-integrated diagnostic systems, radiologist shortages, and precision medicine adoption. Software and medical imaging segments lead the market, while Asia-Pacific is expected to see the fastest regional growth.

05/08/2026, 9:53 AM • GlobeNewswire

Pregnancy Detection Kits Market Analysis Report 2026 - Competitive Landscape, Opportunities, and Forecasts, 2021-2025 & 2025-2031

The global pregnancy detection kits market is projected to grow from USD 1.91 billion in 2025 to USD 2.69 billion by 2031, with a CAGR of 5.87%. Growth is driven by technological advancements enabling earlier detection, rising infertility rates, and increasing adoption of digital integration and e-commerce distribution. However, the market faces challenges from accuracy concerns and user error risks that erode consumer trust.

05/08/2026, 4:47 AM • GlobeNewswire

Coagulation Analyzer Market Size to Reach a Valuation of USD 7.87 Billion by 2035; Increasing Incidence of Blood Disorders to Propel Market Expansion Globally | SNS Insider

The global coagulation analyzer market is projected to grow from USD 4.60 billion in 2025 to USD 7.87 billion by 2035, with a CAGR of 5.55%. Growth is driven by rising blood disorders, increasing surgeries, automation in diagnostics, and cardiovascular disease prevalence. The U.S. market alone is expected to grow from USD 1.50 billion to USD 2.41 billion. Consumables dominate with 64.28% market share, while fully automated systems show the fastest growth at 6.48% CAGR. Hospitals lead end-user segment with 52.84% share, and Asia-Pacific is the fastest-growing region at 7.24% CAGR.

04/22/2026, 10:00 AM • GlobeNewswire

Allergy Diagnostic Market by Product & Service, Test Type, Allergen, End User - Global Forecast to 2031

The global allergy diagnostic market is expected to grow from USD 6.80 billion in 2025 to USD 10.77 billion by 2030, at a CAGR of 9.6%. Growth is driven by technological innovations such as multiplex immunoassays and molecular allergology, rising allergy incidence, and increasing awareness. North America leads the market, with major players including Thermo Fisher Scientific, Siemens Healthineers, and Danaher Corporation dominating the competitive landscape.

04/13/2026, 8:00 AM • GlobeNewswire

Radiopharm Theranostics and Siemens Healthineers Sign Clinical Supply Agreement for RAD101 in the U.S.

Radiopharm Theranostics and Siemens Healthineers announced a supply agreement for RAD101, a novel PET imaging agent for brain metastases. The Phase 2b interim analysis showed 90% concordance with MRI (primary endpoint), with significant tumor uptake. Siemens will manufacture and distribute 18F-labeled RAD101 to support the upcoming Phase 3 registrational trial in the U.S.

04/07/2026, 7:00 AM • GlobeNewswire

IoT in Healthcare Market Led by Home-Care Segment Growing at an 18.32% CAGR; to Reach USD 483.72 Billion by 2031, Reports Mordor Intelligence

The IoT in healthcare market is projected to grow from USD 207.4 billion in 2026 to USD 483.72 billion by 2031, with a CAGR of 18.46%. Growth is driven by remote patient monitoring adoption, connected medical devices, digital health advancements, and declining sensor costs. North America leads the market while Asia-Pacific emerges as the fastest-growing region.

04/06/2026, 3:54 AM • GlobeNewswire

Drug Screening Market Trends 2026–2031: Chromatography and Mass Spectrometry Held a 44.77% Share in 2025 Amid Growing Demand for Advanced Testing, Reports Mordor Intelligence

The global drug screening market is projected to reach USD 20.86 billion by 2031, growing at a CAGR of 16.16%. Chromatography and mass spectrometry technologies dominated with 44.77% market share in 2025. Asia-Pacific is the fastest-growing region, driven by expanding healthcare infrastructure and workplace safety initiatives. Market growth is fueled by increasing adoption across workplaces, healthcare settings, and law enforcement, alongside technological advancements in point-of-care testing and rapid detection devices.

04/03/2026, 3:15 AM • GlobeNewswire

Molecular Diagnostics Market Outlook: Set to Grow at 10%+ CAGR Through 2031 as Precision Medicine and Genetic Testing Advance, Says Mordor Intelligence

The global molecular diagnostics market is projected to reach USD 33.51 billion by 2031, growing at a CAGR of 10.43% from 2026 to 2031. Growth is driven by increasing adoption of precision medicine, advancements in genomic testing technologies, and rising prevalence of infectious and chronic diseases. North America leads the market while Asia-Pacific is expected to be the fastest-growing region.

03/10/2026, 3:32 AM • GlobeNewswire

Respiratory Disease Testing Market Global Forecast Report 2026-2032: $9.32 Bn Opportunities in Integrating Advanced Diagnostics, Leveraging Partnerships, and Enhancing Supply Resilience

The global Respiratory Disease Testing Market is projected to grow from USD 5.99 billion in 2025 to USD 9.32 billion by 2032, with a CAGR of 6.50%. Growth is driven by advances in molecular diagnostics, digital imaging, telemedicine, and strategic partnerships. However, 2025 tariff revisions have impacted supply chains, prompting organizations to adopt flexible sourcing strategies and invest in local production capabilities.

03/05/2026, 4:45 AM • GlobeNewswire

Global Digital Twins in Healthcare Market Set to Hit USD 69.67 Billion by 2035 Driven by Accelerating Adoption of AI-Powered Virtual Modeling and Precision Medicine Initiatives – SNS Insider

The global digital twins in healthcare market is projected to grow from USD 2.22 billion in 2025 to USD 69.67 billion by 2035, with a CAGR of 41.17%. Growth is driven by AI-powered virtual modeling, precision medicine initiatives, and real-time patient data integration. The U.S. market alone is expected to reach USD 27.34 billion by 2035. Key applications include personalized medicine, drug discovery, and clinical research, with hospitals and clinics being the largest end-use segment.

02/24/2026, 6:00 AM • GlobeNewswire